|
Q4 FY2023
As of Feb 29, 2024
|
|
|---|---|
| Cash and cash equivalents (Note 5) | |
| Restricted cash (Note 5) | |
| Prepaid expenses (Note 6) | |
| Amounts receivable | |
| Total Current Asset | |
| Investments (Note 7) | |
| Prepaid financing expense (Note 8) | |
| Exploration and evaluation assets (Note 11) | |
| Total Non-Current Asset | |
| Total Assets | |
| Liabilities and Shareholders’ Equity | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | |
| Flow-through share premium liability (Note 12) | |
| Total Liabilities | |
| Shareholders’ Equity | |
| Capital stock (Note 13) | |
| Contributed surplus (Note 13) | |
| Deficit | |
| Total Shareholders’ Equity | |
| Total Liabilities and Shareholders’ Equity |
Loading...
